Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-11-13, Stock:LLY, The news for the past five days is as follows:
2018-11-06: NEWS1: What Happened in the Stock Market Today.NEWS2: What Happened in the Stock Market Today.NEWS3: Stocks - Dow Rallies as Midterm Mania Grips Wall Street.NEWS4: Eli Lilly & Co (LLY) Q3 2018 Earnings Conference Call Transcript.NEWS5: Eli Lilly & Co (LLY) Q3 2018 Earnings Conference Call Transcript.NEWS6: Eli Lilly Shares Decline on Tuesday Despite Strong Earnings Release.NEWS7: The midterm election could decide the fate of these three health-care groups.NEWS8: What Happened in the Stock Market Today.NEWS9: Mallinckrodt Pops On Quarter Beat As Lilly Dips On Mixed Report.NEWS10: Nasdaq Gains for First Day in Three as U.S. Voters Head to the Polls.NEWS11: Eli Lilly & Co (LLY) Q3 2018 Earnings Conference Call Transcript.NEWS12: Will Stocks Gain After the Elections? & Earnings from CVS, LLY, HEAR.NEWS13: Will Stocks Gain After the Elections? & Earnings from CVS, LLY, HEAR.NEWS14: MarketPulse: Mylan Surges to Keep Health Care Stocks Well Above Flatline.NEWS15: Eli Lilly's Conservative Pricing Offers Protection From Political Pressure.NEWS16: Eli Lilly's Elanco Offload Offers Acquisition Flexibility.NEWS17: Buy Eli Lilly on the pullback? Why isn't Southwest taking....NEWS18: Will Stocks Gain After the Elections? & Earnings from CVS, LLY, HEAR.NEWS19: Eli Lilly Tops Q3 Earnings Estimate, Lifts 2018 Outlook as Diabetes Sales Rise.NEWS20: Mid-Day Update: Wall Street Grinds Higher as Americans Go To the Polls.NEWS21: Mid-Day Update: Wall Street Grinds Higher as Americans Go To the Polls.NEWS22: Stocks Rise in Cautious Trading as America Heads to the Polls.NEWS23: September JOLTS Report In Spotlight.NEWS24: September JOLTS Report In Spotlight.NEWS25: Trulicity leads mixed third quarter for Lilly; shares sink.NEWS26: Eli Lilly’s Big Picture Justifies Its Lofty Valuation.NEWS27: Wall Street Continues to See Opportunity in Eli Lilly.NEWS28: 2 Groups to Watch as the Midterm Election Unfolds: Cannabis and Drug Stocks.NEWS29: Stocks - Wall Street Rises After Upbeat Earnings.NEWS30: Trulicity leads mixed third quarter for Lilly; shares sink.NEWS31: September JOLTS Report In Spotlight.NEWS32: Lilly (LLY) Tops Q3 Earnings, Lifts 2018 Outlook, Stock Up.NEWS33: Tech Stocks Lead Stock Market Rally As Facebook Suspends More Accounts.NEWS34: Stocks Rise Slightly in Cautious Trading as America Heads to the Polls.NEWS35: Health Care Sector Update for 11/06/2018: RGLS, SNY, MYL, LLY, JNJ, PFE, ABT, MRK, AMGN.NEWS36: Health Care Sector Update for 11/06/2018: RGLS, SNY, MYL, LLY, JNJ, PFE, ABT, MRK, AMGN.NEWS37: Eli Lilly Offers Healthy Outlook to Kick Off November.NEWS38: Lilly to consider more acquisitions like $1.6 billion Armo buy.NEWS39: Eli Lilly (LLY) Q3 Earnings Surpass Estimates.NEWS40: Eli Lilly (LLY) Q3 Earnings Surpass Estimates.NEWS41: Eli Lilly Could Hit New Highs, but Market Weakness Could Mute Gains.NEWS42: Eli Lilly Earnings, Revenue beat in Q3.NEWS43: See what the IHS Markit Score report has to say about Eli Lilly And Co..NEWS44: [$$] Eli Lilly Raises 2018 Guidance after Strong 3Q.NEWS45: Stocks making the biggest move premarket: CVS, Eli Lilly, Marriott, Mylan & more.NEWS46: Eli Lilly (LLY) Q3 Earnings Surpass Estimates.NEWS47: Top 5 Things to Know in The Market on Tuesday.NEWS48: Eli Lilly CEO on earnings and drug pricing.NEWS49: Should You Buy Paypal Holdings Inc (PYPL)?.NEWS50: The Daily Biotech Pulse: EyePoint Licenses Eye Inflammation Drug, Insys Strategic Review Of Opioid Assets, Neos Offering.NEWS51: Today's Research Reports on Trending Tickers: GlaxoSmithKline and Eli Lilly and Company.NEWS52: Earnings Reaction History: Eli Lilly & Co., 45.5% Follow-Through Indicator, 2.7% Sensitive.NEWS53: Earnings Reaction History: Eli Lilly & Co., 45.5% Follow-Through Indicator, 2.7% Sensitive.NEWS54: Lilly: 3Q Earnings Snapshot.NEWS55: Eli Lilly beats earnings expectations, raises guidance.NEWS56: Eli Lilly posts top and bottom line beats.NEWS57: Lilly Delivers Solid Third-Quarter 2018 Results, Revises EPS Guidance.NEWS58: Eli Lilly And Co. Q3 18 Earnings Conference Call At 9:00 AM ET.NEWS59: Eli Lilly And Co. Q3 18 Earnings Conference Call At 9:00 AM ET.NEWS60: Eli Lilly Q3 Results Beat View; Lifts FY18 Outlook.NEWS61: Eli Lilly Q3 Results Beat View; Lifts FY18 Outlook.NEWS62: Asian shares meander, oil lower ahead of US midterms vote.
2018-11-07: NEWS1: Better Buy: Eli Lilly and Company vs. AbbVie Inc..NEWS2: Better Buy: Eli Lilly and Company vs. AbbVie Inc..NEWS3: Mallinckrodt (MNK) Beats on Q3 Earnings Estimates, Ups View.NEWS4: Mallinckrodt (MNK) Beats on Q3 Earnings Estimates, Ups View.NEWS5: Better Buy: Eli Lilly and Company vs. AbbVie Inc..NEWS6: Mallinckrodt (MNK) Beats on Q3 Earnings Estimates, Ups View.NEWS7: What AbbVie’s Bottom Line Trend Indicates.NEWS8: A Look at AbbVie’s Operational Performance.NEWS9: How AbbVie Is Positioned in November.NEWS10: Drug Stocks Climb as Investors Digest Midterm Election Results.NEWS11: Amgen (AMGN) Counts on New Drugs Amid Rising Biosimilar Woes.NEWS12: Amgen (AMGN) Counts on New Drugs Amid Rising Biosimilar Woes.NEWS13: Noteworthy ETF Outflows: XLV, AMGN, MDT, LLY.NEWS14: Noteworthy ETF Outflows: XLV, AMGN, MDT, LLY.NEWS15: Sanofi Eczema Drug Dupixent's sBLA Gets Priority Review.NEWS16: Sanofi Eczema Drug Dupixent's sBLA Gets Priority Review.NEWS17: Edited Transcript of LLY earnings conference call or presentation 6-Nov-18 2:00pm GMT.
2018-11-08: NEWS1: Novo Nordisk Continues Its Balancing Act.NEWS2: Novo Nordisk Continues Its Balancing Act.NEWS3: Lilly to Participate in Credit Suisse 27th Annual Healthcare Conference.NEWS4: Novo Nordisk Continues Its Balancing Act.NEWS5: Horizon Pharma (HZNP) Q3 Earnings & Sales Beat, Shares Rise.NEWS6: Horizon Pharma (HZNP) Q3 Earnings & Sales Beat, Shares Rise.NEWS7: AstraZeneca's (AZN) Q3 Earnings Beat, New Drugs Drive Sales.NEWS8: AstraZeneca's (AZN) Q3 Earnings Beat, New Drugs Drive Sales.NEWS9: Nektar (NKTR) Q3 Earnings & Sales Beat Estimates, Shares Up.NEWS10: Nektar (NKTR) Q3 Earnings & Sales Beat Estimates, Shares Up.NEWS11: Horizon Pharma (HZNP) Q3 Earnings & Sales Beat, Shares Rise.NEWS12: Nektar (NKTR) Q3 Earnings & Sales Beat Estimates, Shares Up.NEWS13: How Analysts Rate AbbVie Stock.NEWS14: 7 Healthcare Stocks Soaring on Election Results.NEWS15: 7 Healthcare Stocks Soaring on Election Results.
2018-11-09: NEWS1: Catalyst (CPRX) Reports Q3 Loss as Expected & Pipeline Update.NEWS2: Catalyst (CPRX) Reports Q3 Loss as Expected & Pipeline Update.NEWS3: Keryx's (KERX) Loss Narrower Than Expected in Q3, Sales Lag.NEWS4: Keryx's (KERX) Loss Narrower Than Expected in Q3, Sales Lag.NEWS5: Catalyst (CPRX) Reports Q3 Loss as Expected & Pipeline Update.NEWS6: Keryx&apos;s (KERX) Loss Narrower Than Expected in Q3, Sales Lag.NEWS7: Celldex (CLDX) Q3 Earnings Beat Estimates, Revenues Miss.NEWS8: Celldex (CLDX) Q3 Earnings Beat Estimates, Revenues Miss.NEWS9: See what the IHS Markit Score report has to say about Eli Lilly And Co..NEWS10: Pharma Stock Roundup: LLY, AZN Report Q3 Earnings, PFE Gets FDA Nod for Cancer Drug.
2018-11-12: NEWS1: Eli Lilly (LLY) Gains As Market Dips: What You Should Know.NEWS2: IBD Stock Of The Day Nears Buy Point As It Outperforms Big Pharma Rivals.NEWS3: 5 Stocks to Sell After the Midterm Election.NEWS4: AVEO Pharmaceuticals (AVEO) Q3 Earnings & Revenues Top Mark.NEWS5: AVEO Pharmaceuticals (AVEO) Q3 Earnings & Revenues Top Mark.

Answer: Decrease